Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2016 Dec;95(50):e5565.
doi: 10.1097/MD.0000000000005565.

Clinical characteristics of immune thrombocytopenia associated with autoimmune disease: A retrospective study

Affiliations
Observational Study

Clinical characteristics of immune thrombocytopenia associated with autoimmune disease: A retrospective study

Yuan Liu et al. Medicine (Baltimore). 2016 Dec.

Abstract

To clarify clinical characteristics of immune thrombocytopenia (ITP) subsets associated with autoimmune diseases (AIDs).Five thousand five hundred twenty patients were reviewed retrospectively. One hundred four ITP patients were included for analysis. Clinical manifestations at first thrombocytopenic episode were recorded.Systemic lupus erythematosus (SLE) and primary Sjogren syndrome (pSS) accounted for a large part in AIDs associated with secondary ITP. SLE-ITP, pSS-ITP, and primary ITP (pITP) patients were different in several aspects in clinical and immunological characteristics. A subgroup of patients in pITP patients with some obvious autoimmune features (defined as AIF-ITP) such as positive ANA but failing to meet the diagnosis criteria now used for a specific kind of connective tissue diseases were also different with other pITP patients in some immunological features, indicating the difference in the pathogenesis mechanism of those autoimmune featured ITP patients.ITP patients were heterogeneous in clinical characteristics. Further study about the different pathogenesis of ITP subsets especially those AIF-ITP patients who only presented with thrombocytopenia will help us have a better understanding of pathogenesis of ITP and a better management of ITP patients.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Correlation of different immunological variables with PLT. (A) The correlation between C3 level and PLT in ITP patients was determined using Spearman correlation coefficients, n = 85. (B) The correlation between C4 level and PLT in ITP patients was determined using Spearman correlation coefficients, n = 85. (C) The correlation between IgG level and PLT in ITP patients was determined using Spearman correlation coefficients, n = 85. (D) The correlation between T cell percentage in peripheral blood lymphocytes and PLT in ITP patients was determined using Spearman correlation coefficients, n = 16. (E) The correlation between B cell percentage in peripheral blood lymphocytes and PLT in ITP patients was determined using Spearman correlation coefficients, n = 7. (F) The correlation between NK cell percentage in peripheral blood lymphocytes and PLT in ITP patients was determined using Spearman correlation coefficients, n = 10.

References

    1. Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010;115:168–86. - PubMed
    1. Cines DB, McMillan R. Pathogenesis of chronic immune thrombocytopenic purpura. Curr Opin Hematol 2007;14:511–4. - PubMed
    1. Provan D, Newland AC. Current management of primary immune thrombocytopenia. Adv Ther 2015;32:875–87. - PMC - PubMed
    1. Cines DB, Bussel JB, Liebman HA, et al. The ITP syndrome: pathogenic and clinical diversity. Blood 2009;113:6511–21. - PMC - PubMed
    1. Ziakas PD, Giannouli S, Zintzaras E, et al. Lupus thrombocytopenia: clinical implications and prognostic significance. Ann Rheum Dis 2005;64:1366–9. - PMC - PubMed

Publication types

MeSH terms

Substances